Company page

Kanaph Therapeutics Inc.

Kanaph Therapeutics Inc. is a public company traded under the ticker 0082N0 on the Korean market. The company has a market capitalization of approximately 161.79 million. Kanaph Therapeutics focuses on developing innovative therapeutic solutions.

profile0082N0:KRXAI content: aiUpdated June 24, 2026/company/kanaph-therapeutics-inc/c-9smtxhtf
Kanaph Therapeutics Inc. logo
Ticker
0082N0:KRX
Asset type
Stock
Market cap
$161.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
KRX
Currency
KRW